Atrial fibrillation (AF) is a major risk factor for stroke. Despite substantial advances in both the treatment for AF and the prevention of AF related strokes, fundamental questions on pathophysiological mechanisms, risk assessment, prevention and therapy are still unresolved. There is an unmet medical need for clinically applicable concepts in AF diagnostic workup and individual patient risk evaluation.
Scientific program nucleus
20 internationally renowned experts in AF and stroke prevention with high clinical and academic standing. A full time in-person attendance is required to ensure recognition of consensus voting (no
late arrival or early departure).